National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Smoking Cessation and Continued Risk in Cancer Patients (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 08/14/2008
Nicotine Patches

  Brand  Dose   Side Effects   Comments 
OTC = over the counter; Rx = prescription.
Rx Habitrol 7–21 mg/day Erythema Use for 6–12 weeks.
OTC Nicoderm CQ 7–21 mg/day Pruritus Use for 6–12 weeks.
OTC Nicotrol 5–15 mg/day Burning at site Use for 14–20 weeks.
Rx ProStep 11–22 mg/day Local irritation Use for 6–12 weeks.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov